Month: August 2013

ESC Congress 2013

New research is being presented at ESC Congress 2013, the annual meeting of the European Society of Cardiology, from August 31 to September 4 in Amsterdam, Netherlands. Meeting Highlights Women Benefit With Drug-Eluting Stents...

Read More

FDA Approves Tivicay for HIV Infection

The U.S. Food and Drug Administration today approved Tivicay (dolutegravir), a new drug to treat HIV-1 infection. Tivicay is an integrase strand transfer inhibitor that interferes with one of the enzymes necessary for HIV to...

Read More